augmentin dose for tooth infection Dr Trevor Lawley, is the Faculty Group Leader of the Host-Microbiota Interactions Team, at the Wellcome Trust Sanger Institute. Trevor’s research uses high-throughput genome sequencing to investigate the microbial communities contained on and within host organisms that are associated with health and disease. He uses clinical samples and mouse models to identify the pathogen and host factors that are linked to disease and infectivity.inderal la 120 mg cost
too high dose of strattera Trevor obtained his PhD from the University of Alberta, Canada, where he studied the mechanisms that pathogenic bacteria use to disseminate antibiotic resistance genes. His PhD thesis culminated in 2004 with him receiving the ‘Gold Award’ (Graduate Student of the Year) from the Canadian Society of Microbiologists.
teva-clonidine tdah belgique After his PhD Trevor was awarded a Canadian Institutes of Health Research post-doctoral fellowship to work in the Laboratory of Professor Stanley Falkow and Dr Denise Monack at Stanford University, USA, where he studied the impact of antibiotic treatment on Salmonella disease and transmission. In 2007 Trevor received a Royal Society of London Award – sponsored by Professor Gordon Dougan – to start a research programme on Clostridium difficile disease and transmission within the Microbial Pathogenesis group at the Wellcome Trust Sanger Institute.
propranolol ersatz 52 In 2016, Trevor co-founded and is Chief Scientific Officer for Microbiotica, a biotech company based at the Wellcome Genome Campus in Hinxton, Cambridge, to exploit research by his lab into the role of the human microbiome in health and disease and its potential clinical applications.